Your session is about to expire
← Back to Search
Telemedicine Referral for Childhood Hearing Loss
Study Summary
This trial will test whether a new telemedicine intervention called STAR can reduce loss to follow-up in rural Alaska after school hearing screenings. It will compare the intervention to the standard referral of a letter home to families, and evaluate over three academic years.
Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
Is eligibility for this experiment restricted to adults?
"The requisite age range for joining this trial is 3 to 21 years old. 59 studies are available for minors, while 146 cater to senior citizens."
Are there any eligibility criteria I must meet in order to participate in this experiment?
"This research study is seeking 6045 people aged 3-21 who suffer from hearing loss. Additionally, they must be students enrolled in one of the participating schools within three geographic regions and their grade level (K-12) should comply with the normal screening process for those schools. There are no age, gender, racial or ethnic constraints on eligibility."
Is there still an opportunity to join this research endeavor?
"Indeed, per the information on clinicaltrials.gov this medical research is still recruiting participants. It was initially posted on September 1st 2023 and edited October 24th of that same year. 6045 patients are sought by one location for inclusion in the study."
What is the total enrollment number for this experiment?
"Affirmative. Data available on clinicaltrials.gov attests that this trial, which was originally posted on September 1st 2023 is now actively recruiting patients. The medical study seeks to enrol 6045 individuals across a single site."
Share this study with friends
Copy Link
Messenger